Skip to content

Multigene-Edited Pig-to-Rhesus-Macaque Liver Xenotransplantation: Multifaceted Profiling-of-Post-transplant Phenotypes.

Sep 2026 · Xenotransplantation · Vol 33 5, pp. e70175 · 0 citations · 54 references
Medicine

TL;DR

Although xenoantigen knockout effectively averts HAR, irreversible coagulation-cascade activation, thrombosis and consumptive coagulopathy still represent the principal barriers to long-term xenograft survival even in the setting of donor-expressed human anticoagulant transgenes hTBM, hCD39, and hEPCR.

Abstract

The shortage of donor livers motivates the development of pig-to-non-human-primate liver xenotransplantation. While gene-editing-mediated xenoantigen knockout reliably prevents hyperacute rejection (HAR), nevertheless, the integrated in-vivo phenotype and coagulation-associated complications of multi-gene-edited porcine livers remain poorly characterized. To address this knowledge gap, we established orthotopic auxiliary partial liver xenotransplantation in non-human primates using 6-, 8-, and 10-gene-edited porcine donors, and performed multi-modal longitudinal phenotyping covering graft function assessment, immune-coagulation profiling, PERV/PCMV DNA screening, as well as mechanistic analyses of graft injury. Consistent with prior reports, all three transplantations succeeded; xenoantigen knockout prevented HAR, and grafts maintained basal function with only mild sinusoidal congestion and limited complement-antibody deposition. Strikingly, every recipient developed severe thrombocytopenia, graft thrombosis, and thrombotic microangiopathy, which ultimately culminated in graft dysfunction. Further analyses revealed that aberrant endothelial ASGR1 and vWF expression together with porcine macrophage-mediated platelet clearance constituted principal drivers of platelet depletion; meanwhile, PERV and PCMV DNA were undetectable in recipient tissues. Collectively, although xenoantigen knockout effectively averts HAR, irreversible coagulation-cascade activation, thrombosis and consumptive coagulopathy still represent the principal barriers to long-term xenograft survival even in the setting of donor-expressed human anticoagulant transgenes hTBM, hCD39, and hEPCR. These findings provide valuable insights for future donor-engineering and complication-intervention strategies.

View source

Similar papers

#gene editing Review Open access Sep 2026

Beyond conventional immunosuppression: tailoring perioperative management protocols for clinical xenotransplantation

This review proposes a standardized perioperative management protocol that is applicable to clinical xenotransplantation and addresses consumptive coagulopathy; targeted suppression of macrophage- and neutrophil-driven innate inflammatory cascades, alongside activation of xenoreactive natural killer cells.

Kyu-Hyun Han, J. Yang · 0 citations
Review Open access Sep 2026

Xenotransplantation of the Porcine Lung—From Immunological Barriers to Emerging Experimental Strategies

This review summarizes the current knowledge on immunological barriers in lung xenotransplantation, including mechanisms of hyperacute, delayed, and chronic rejection, and highlights potential experimental strategies to overcome the various rejection responses.

N. Roters, Niveditha Varma, R. Ramm et al. · 0 citations
Review Sep 2026

Multiomic analyses in xenotransplantation: Hypothesis generation and the path toward precision diagnostics.

The use of multiomics as a hypothesis-generating tool to guide next-generation donor-pig design and adjust immunosuppression is summarized, while exploring its contribution to the diagnosis of xenograft rejection.

J. Ladowski, A. Sannier, Alexandre Loupy et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.